Literature DB >> 9711774

Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity.

Y Suen1, S M Lee, J Qian, C van de Ven, M S Cairo.   

Abstract

Haematopoiesis and immune functions in cord blood (CB) are developmentally immature when compared with adult peripheral blood (APB). The defects in CB immune function and cytokine production may both contribute to the immaturity of CB immunity. We have studied the mechanisms associated with the dysregulation of myeloid lineage cytokines, GM-CSF and M-CSF, and lymphokines, IL-12, and IL-15 in activated CB when compared with APB MNC. Furthermore, we have studied the effects of IL-12 and IL-15 on induction of IFN-gamma and TNF-alpha production, NK, and LAK activities in CB and APB. GM-CSF, M-CSF, IL-12 and IL-15 protein and mRNA are decreased in activated CB MNC. These discrepancies are secondary, at least in part, to the altered post-transcriptional regulation. The impaired ability of CB to produce IL-12 and IL-15 in response to stimulation may contribute to the decrease in IFN-gamma, TNF-alpha production, NK and LAK activities. Furthermore, combination of low dose IL-12 and IL-15 may augment cytotoxic activities and minimize toxicity. These findings suggest that reduced cytokine expression from activated CB may contribute to the impaired CB cellular immunity and exogenous lymphokines may compensate for the immaturity in CB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711774     DOI: 10.1016/s0264-410x(98)00094-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

2.  T-lymphocyte recovery and function after cord blood transplantation.

Authors:  Paul Szabolcs
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.

Authors:  Archana Thakur; Carly Sorenson; Oxana Norkina; Dana Schalk; Voravit Ratanatharathorn; Lawrence G Lum
Journal:  Transfusion       Date:  2011-07-11       Impact factor: 3.157

4.  Different roles for LFA-1 and VLA-4 integrins in T-B-cell interactions in vivo.

Authors:  M López-Hoyos; C Revilladagger; C Conde; E G Del Campo; A González; J Merino
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

Review 5.  Immune reconstitution after unrelated cord blood transplantation.

Authors:  P Szabolcs; D Niedzwiecki
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

6.  Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood.

Authors:  Seok-Gu Kang; Chung Hun Ryu; Sin Soo Jeun; Chun Kun Park; Hyung-Jin Shin; Jong Hyun Kim; Moon Chan Kim; Joon Ki Kang
Journal:  Childs Nerv Syst       Date:  2004-02-13       Impact factor: 1.475

7.  Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.

Authors:  Annelies Van Rie; Shabir A Madhi; Jayvant R Heera; Stephen Meddows-Taylor; Aaron M Wendelboe; Fiona Anthony; Avy Violari; Caroline T Tiemessen
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 8.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.

Authors:  Michael R Verneris; Jeffrey S Miller
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

Review 9.  T cell immunity in neonates.

Authors:  A M Garcia; S A Fadel; S Cao; M Sarzotti
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

10.  The immunobiology of cord blood transplantation.

Authors:  Paul Szabolcs
Journal:  Korean J Hematol       Date:  2010-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.